Pediatrix Medical Group GC Mary Ann Moore to depart Oct 31; David Haddock appointed successor

Pediatrix Medical Group, Inc.

Mary Ann Moore will transition to advisory role until October 31, 2026, then leave the company.
Separation agreement with PMG Services; termination without cause triggers benefits under employment agreement.
David Haddock appointed Executive Vice President, General Counsel and Secretary effective immediately.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.